Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
Sponsor: Respicardia, Inc.
Terminated
Change in company priorities
Other Central Sleep Apnea trials with similar outcome
A observational or N/A phase clinical study on Central Sleep Apnea and Heart Failure, this trial is terminated or withdrawn. The trial is conducted by Respicardia, Inc. and has accumulated 7 data snapshots since 2011. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Aug 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Respicardia, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .